Motzer R J, Amsterdam A, Prieto V, Sheinfeld J, Murty V V, Mazumdar M, Bosl G J, Chaganti R S, Reuter V E
Department of Medicine, Memorial Hospital, New York, New York, USA.
J Urol. 1998 Jan;159(1):133-8. doi: 10.1016/s0022-5347(01)64035-7.
Teratoma with malignant transformation refers to a form of germ cell tumor in which a somatic teratomatous component becomes morphologically malignant and develops aggressive growth. We evaluated the spectrum of histologies, chromosomal abnormalities and clinical outcome in patients with teratoma with malignant transformation.
We identified 46 patients with germ cell tumor meeting morphologic criteria for malignant transformation. Histology, disease extent and treatment were correlated with survival. Tumors in 12 patients were studied by conventional cytogenetics or molecular genetic techniques for the isochromosome 12p [i(12p)], a marker for germ cell tumor, as well as other chromosomal abnormalities.
The site of first detection of malignant transformation occurred in the primary tumor of 21 cases (44%), at a metastatic site in 20 (43%) and in both sites in 5 (10%). Sarcoma was the most frequent histology, identified in 29 patients (63%) with rhabdomyosarcoma the most common subtype. Seventeen tumors (37%) contained a solid tumor histology other than sarcoma, with adenocarcinoma and primitive neuroectodermal tumor as the most common histologies. Four patients with mediastinal germ cell tumor containing sarcoma also had hematological malignancies, including a focus of nonHodgkin's lymphoma in the mediastinal primary tumor (1) and nonlymphocytic leukemia in spleen or bone marrow (3). Patients who had teratoma with malignant transformation components confined to the testis or retroperitoneum completely resected experienced a longer survival than those with distant metastases or incompletely resected tumors (p = 0.003). Chromosomal abnormalities associated with germ cell tumor (i[12p]) were identified in 11 of 12 tumors containing adenocarcinoma, primitive neuroectodermal tumor, sarcoma and leukemia. In addition to i (12p), chromosomal rearrangements characteristic of the transformed histology were detected in 4 tumors.
A variety of nongerm cell histologies, including sarcoma, adenocarcinoma, primitive neuroectodermal tumor and leukemia, may occur in association with germ cell tumor. Chromosomal abnormalities in these tumors include i (12p), reflecting germ cell tumor clonality, as well as chromosomal abnormalities associated with the transformed histology. These tumors do not respond like germ cell tumor to cisplatin-containing chemotherapy regimens. Treatment should be tailored according to that used in standard management of the transformed histology, and surgical resection is the mainstay of therapy.
伴有恶性转化的畸胎瘤是一种生殖细胞肿瘤,其中体细胞性畸胎瘤成分发生形态学上的恶性改变并出现侵袭性生长。我们评估了伴有恶性转化的畸胎瘤患者的组织学类型、染色体异常及临床结局。
我们确定了46例符合恶性转化形态学标准的生殖细胞肿瘤患者。将组织学、疾病范围及治疗与生存情况进行关联分析。对12例患者的肿瘤采用传统细胞遗传学或分子遗传学技术研究12号染色体短臂等臂染色体[i(12p)],这是生殖细胞肿瘤的一个标志物,以及其他染色体异常情况。
恶性转化首次检测部位发生在原发肿瘤的有21例(44%),发生在转移部位的有20例(43%),同时发生在这两个部位的有5例(10%)。肉瘤是最常见的组织学类型,在29例患者(63%)中被识别出,其中横纹肌肉瘤是最常见的亚型。17例肿瘤(37%)包含除肉瘤外的实体瘤组织学类型,腺癌和原始神经外胚层肿瘤是最常见的组织学类型。4例纵隔生殖细胞肿瘤合并肉瘤的患者还患有血液系统恶性肿瘤,包括纵隔原发肿瘤中有1例非霍奇金淋巴瘤病灶,以及脾脏或骨髓中有3例非淋巴细胞白血病。伴有恶性转化成分局限于睾丸或腹膜后的畸胎瘤患者,若肿瘤完全切除,其生存期比有远处转移或肿瘤切除不完全的患者更长(p = 0.003)。在12例包含腺癌、原始神经外胚层肿瘤、肉瘤和白血病的肿瘤中,有11例检测到与生殖细胞肿瘤相关的染色体异常(i[12p])。除i(12p)外,在4例肿瘤中还检测到了与转化后的组织学特征相关的染色体重排。
多种非生殖细胞组织学类型,包括肉瘤、腺癌、原始神经外胚层肿瘤和白血病,可能与生殖细胞肿瘤相关。这些肿瘤中的染色体异常包括i(12p),反映生殖细胞肿瘤的克隆性,以及与转化后的组织学相关的染色体异常。这些肿瘤对含顺铂的化疗方案反应不像生殖细胞肿瘤那样。治疗应根据转化后的组织学标准管理中使用的方法进行调整,手术切除是主要的治疗手段。